Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Larotrectinib Capsules 25 mg and 100 mg.
Alembic Pharmaceuticals: Announcement under Regulation 30 (LODR)-Press Release / Media Release
11-Jun-2026
Download PDF
Alembic Pharma
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month